Drawing for SUPER I

USPTO serial 87907317

SUPER I

Reviewed by CopyMark Law Group

Reg. 5617398Status 702Registered
Filing date
Status date
Registration date
Nov 27, 2018
Examiner
COLLOPY, DIANE PATRICIA
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with SUPER I?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bruce S. Londa

Bruce S. Londa Norris McLaughlin, P.A.7 Times Square21st FloorNew York, NY 10036

Goods and services

ClassDescriptionStatusFirst use
001Phosphoramidites of modified bases, nucleoside triphosphates of modified bases, activated monomers of modified bases, modified nucleotide bases, oligonucleotide conjugates, DNA primers, oligonucleotides, and oligomer probes, for scientific and research use, nucleic acid detection, genetic analysis, and synthesis of oligopolymers, together with instruction manuals therefor packaged as a unitACTIVEJun 29, 2015
005Phosphoramidites of modified bases, nucleoside triphosphates of modified bases, activated monomers of modified bases, modified nucleotide bases, oligonucleotide conjugates, DNA primers, oligonucleotides, and oligomer probes, for medical and pharmaceutical use, together with instruction manuals therefor packaged as a unitACTIVEJun 29, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 11, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 2, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 2, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 16, 2025EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Mar 18, 2025PR23POST REGISTRATION ACTION MAILED - SEC. 8 & 15—
Mar 10, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 29, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 8, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Nov 27, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 27, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 11, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 11, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 22, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 7, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 1, 2018DOCKASSIGNED TO EXAMINER—
May 14, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 8, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance